ABSTRACT
Background: Diabetes Mellitus refers to a group of common metabolic disorders that share the phenotype of Hyperglycemia. It is the leading cause of morbidity and mortality throughout the world with an estimated worldwide prevalence of 439 million by 2030 and 19% of world抯 DM patients are Indians. Magnesium is an important co-factor for various enzymes involved in Insulin secretion and is involved in sodium-potassium ATPase pump. 25%-38% of Type 2 DM patients had Hypomagnesemia, which has also contributed in developing microvascular complications such as Diabetic Retinopathy (DR) and Diabetic Nephropathy (DN). Various studies have suggested that Magnesium supplementation in Type 2 DM patients with Hypomagnesemia have shown beneficial effects on insulin sensitivity and glucose metabolism. Aim and objectives: To study the prevalence of Hypomagnesemia in Type 2 DM patients and to study the association of Hypomagnesemia with microvascular complications such as DR and DN. Materials and methods: It is a hospital based Observational study carried out in 2022 for a period of 1 year including 60 patients fulfilling the ADA criteria for diagnosing T2DM and patients with Diabetic Retinopathy and Diabetic Nephropathy, and excluding patients with Malabsorption, Chronic diarrhoea, Renal Failure on diuretic therapy, Sepsis, Pancreatitis. Serum Magnesium levels of 1.6 mg/dl � 2.6 mg/dl is considered as normal range. Serum Magnesium were measured using Xylidyl blue colorimetric method. Results: The Mean age of the patients in our study was 55.89 years. Among 60 patients diagnosed with Diabetes Mellitus, 42 patients had Hypomagnesemia, 18 patients had Normomagnesemia (p- value: <0.0001). Patients with an HbA1c levels > 7% had Hypomagnesemia when to compared to patients with HbA1c <7% with a significant p value of 0.009. Hypomagnesemia was also associated with Diabetic Retinopathy and Diabetic Nephropathy with a significant p-value of 0.013 and 0.009 respectively. Conclusion: In our study, it has shown that patients with uncontrolled T2DM had Hypomagnesemia, which is also associated with micro-vascular complications of T2DM such as DR and DN.
ABSTRACT
Background: Cardiovascular disease is one of the leading causes of mortality, morbidity, and increased health-care cost. Magnesium has been implicated in the pathogenesis of acute myocardial infarction (AMI) and its complications. Magnesium ions are considered essential for the maintenance of functional integrity of myocardium. The serum magnesium concentration was found to have great significance in AMI. The present study was undertaken to evaluate the prognostic value of serum magnesium in AMI. Aim and Objectives: The aim of the study was (1) to evaluate serum magnesium levels in patients of AMI on 1st and 7th day post-myocardial infarction and (2) to evaluate validity of serum magnesium as prognostic indicator of Ami. Materials and Methods: This observational cross-sectional study was conducted in the Medicine Department, Guru Nanak Dev Hospital attached to Govt. Medical College, Amritsar. A total of 40 patients of AMI were enrolled in this study. Serum magnesium levels were done for all the patients and its correlation with clinical outcome was observed. Results: On day 1, mean serum magnesium levels in patients with ST-segment elevation myocardial infarction were 1.638 ± 0.19 whereas mean serum magnesium levels in patients with Non-ST-segment elevation myocardial infarction were 2.315 ± 0.321. Mean serum magnesium levels in patients with arrhythmias were 1.73 ± 0.35 on day 1 and 2.14 ± 0.25 on day 7 (P < 0.05). Mean serum magnesium levels at day 1 in patients having mortality are 1.452 ± 0.078 as compared to 2.105 ± 0.399 in rest of surviving patients. It was inferred from this study that patients with AMI with low serum magnesium levels are more prone to develop complications such as arrhythmias and death as compared to patients of AMI with normal serum magnesium levels. Conclusion: Magnesium is an underestimated cation and has been implicated in the pathogenesis of AMI and its complications. Patients of AMI with low serum magnesium levels are found to be more prone to develop arrhythmias as compared to those with normal serum magnesium levels. Hence, it can be concluded that measurement of serum magnesium level is of prognostic significance in AMI.
ABSTRACT
Background: Preeclampsia is a clinical condition in which the patient is suffering from hypertension and proteinuria, which may be associated with pathological edema. There are multiple systems involved in pre-eclampsia which is the main culprit to complicate the pregnancy. In developing nations, approximately 4–18% of pregnancies are complicated by preeclampsia which is a major cause of morbidity and mortality globally. It does not affect pregnant females only, but may be life-threatening for growing fetuses too. If we consider the mortality in all pregnant females, about 10–15% of maternal deaths are due to pre-eclampsia. Aims and Objectives: The main objective of this study is to compare the serum calcium, magnesium, sodium and potassium level in preeclampsia patients and normal pregnant women. Materials and Methods: After taking written consent from the patients, randomly 50 pregnant females diagnosed by a gynecologist as suffering from preeclampsia were selected and for the control group 50 pregnant females who came for routine checkups were selected. 5 ml of blood was collected in the clot activator tube. The samples were analyzed for serum calcium, magnesium, sodium, and potassium on a fully automated biochemistry analyzer ”Erba XL 640” in HiTech, clinical biochemistry laboratory, B.J medical college, Ahmedabad. Results: The result showed a decreased level of serum calcium, magnesium, sodium, and potassium in the study group compared to the control group. The S. calcium level was (7.624 ± 0.84) and (8.52 ± 0.80) mg/dl in the study and control groups respectively. The S. magnesium level in the study and control were (1.47 ± 0.25) and (1.79 ± 0.18) mg/dl, respectively. S. sodium levels were (131.46 ± 6.96) and (139.92±7.86) mEq/L in the study and control groups, respectively. And the level of S. potassium in the study and control groups was (3.39 ± 0.52) and (3.67 ± 0.38) mEq/L, respectively. All the parameter values are significantly lower in a study group in comparison to control group patients (P < 0.001). Conclusion: From our study, we have concluded that the serum level of some parameters such as calcium, magnesium, sodium, and potassium was significantly decreased in patients suffering from preeclampsia. We can also conclude that these parameters can be used as a biomarker for the diagnosis of preeclampsia.
ABSTRACT
Background: In 2016, 6.3 million cases of PTB were reported by WHO. Magnesium is extremely essential for life and is present as intracellular ion in all living cells and tissues¹. Some workers have found serum Magnesium level to decrease in cases of PTB, which rises towards normal with specific treatment. Objectives: 1. To estimate and compare serum Magnesium levels in cases and controls 2. To measure correlation between Magnesium levels and severity of PTB Materials and Methods: This was a prospective case control study, conducted on 30 PTB patients and 30 controls who met the inclusion and exclusion criteria of the study. This study was done in S.Nijalingappa Medical College, Bagalkot, Karnataka during the period September 2021 to January 2022. All patients were clinically evaluated and underwent relevant investigations. Results: There was significant decrease in Serum Magnesium in cases and more decreased in moderately advanced and far advanced disease. Conclusion: The study concludes that there is significant reduction in Serum Magnesium in PTB and it further decreases as the severity of PTB increases, hence necessitating early treatment of PTB and need for Magnesium supplementation in PTB patients.
ABSTRACT
Background: Magnesium (Mg) is one of the dominant intracellular cations. It catalyzes more than 300 intracellular reactions and has multiple functions in areas of energy production, intracellular calcium regulation, protein synthesis and degradation, and neurotransmitter release. To estimate the prevalence of hypomagnesaemia among patients with type 2 diabetes attending a tertiary care Hospital.Material & Methods:A cross-sectional study was carried out at the Bangladesh Institute of Research and Rehabilitation in Diabetes (BIRDEM), which treats patients with Diabetes Mellitus from all over the country. A total of 754 patients were included and analyzed in this study. All patients with type 2 diabetes who were referred to the BIRDEM during the period from the first of July 2020 to the end of June 2021 and had their serum Mg assessed were included in the study.Results:Out of 754 patients with type 2 diabetes, 150 patients (19.89%) (95% CI, 16.8%-21.4%) were hypomagnesaemic. Female gender, hypertension, statin therapy, HbA1c between 7-7.9% or ? 9% and patients with diabetes duration more than five years were independent risk factors for hypomagnesaemia. No association between hypomagnesaemia and age distribution, smoking history, neuropathy and retinopathy was found. In comparison with individuals enrolled in the National Vitamin D study, diabetic patients in this study had a much higher prevalence of hypomagnesaemia (19% vs. 0.7%) with odd’s ratio of 32 (95% CI, 21-48.2).Conclusions:The present study has shown that an apparently-healthy elderly population may have a magnesium deficiency that may need to be identified and treated for optimizing clinical care. Further multicentric studies with a greater sample size should be done in this field, which will benefit the elderly population.
ABSTRACT
Background: Acute kidney injury is a common problem with various causes and consequences like electrolyte disturbances in the form of hypocalcaemia, hypokalemia, hyperkalemia depending on the phase. Hypomagnesaemia is one of the most common electrolyte disturbance found in hospitalized patients especially in the critically ill patients. Prevalence of hypomagnesemia varies from 11 to 65% in different studies. Hence, we decided to conduct a study to evaluate correlation of serum magnesium levels in AKI.Methods: A cross-sectional, hospital based time bound study was conducted between November 2016 and August 2018 with a sample of 100 patients aged 18-65 years and who had AKI were included and patients with diabetes mellitus, multi-organ dysfunction, obstructive uropathy and drug induced AKI were excluded from study. The decrease in magnesium <1.7 mg/L was defined as hypomagnesaemia. AKI was defined as per AKIN criteria. Day 1, day 3 and day 6 magnesium levels were measured.Results: Prevalence of hypomagnesaemia was 53%, 30% and 36% on day 1, day 3 and day 6 respectively. It was observed that there was a positive correlation between serum magnesium, and serum creatinine. Normomagnsemia and hypermagnesemia on day 1, 3 and 6 were significantly associated with recovery of AKI (p<0.001).Conclusions: The prevalence of hypomagnesemia was significantly higher in AKI patients and normal magnesium and hypermagnesium on day 1, 3 and day 6 was associated with recovery than non-recovery. Hypomagnesemia was associated more with non-recovery then recovery.
ABSTRACT
Background: Hypertensive disorders are major factors responsible for morbidity and mortality in pregnancy and pre-eclampsia is the leading cause. The etiopathology of pre-eclampsia is not known even after significant research done on it. A strong strategy in its management is to try to reduce the incidence and severity by predicting its occurrence. In this study, the effect of serum calcium and serum magnesium levels is being investigated with occurrence pre-eclampsia.Methods: Total 120 pregnant patients attending Tirath Ram Shah Hospital were included in the study. They were divided into two groups namely normotensive and hypertensive of 60 each. The serum calcium and serum magnesium levels were estimated and the correlation of these levels was studied with the pre-eclampsia related factors. The data was analysed by application of statistical test of significance.Results: Mean serum calcium level in the normotensive group was 10.119±1.27 mg/dl while mean serum calcium level in the hypertensive group was 9.461±1.164. Mean serum magnesium level in the normotensive women in the study was 1.979±0.405 mg/dl. In the hypertensive women, mean serum magnesium level was 1.723±0.414 mg/dl.Conclusions: This study shows that low levels of calcium and magnesium are found in serum of pre-eclampsia patients as compared to normotensive cases of the study population. The severity of pre-eclampsia is inversely proportional to the levels of serum calcium and magnesium.
ABSTRACT
Background: The objective of present study was to measure the serum magnesium levels in preterm labor patients, to measure the serum magnesium levels in term labor patients and to correlate the serum magnesium levels in preterm and term labor patients.Methods: It is a prospective case control study conducted in the department of obstetrics and gynecology, KIMS hospital and research Centre, Bengaluru, Karnataka, India. A venous blood sample is drawn from patients admitted to labor room who fulfill the inclusion and exclusion criteria out of which 50 patients belong to the Group-A (preterm labor) and 50 patients belong to Group-B (term labor). Serum magnesium level is measured in both the groups.Results: Women with preterm labor had a significantly reduced serum magnesium level with a mean serum magnesium level of 1.59 mg/dl with a SD of 0.83 whereas the patients with term labor had a mean serum magnesium level of 2.55 mg/dl with a SD of 0.40. The difference of serum magnesium levels observed between the study population and control population is independent of factors like maternal age, parity, gestational age, and socio-economic factors. In this study, it is found that serum magnesium levels are lower in early and late preterm compared to preterm between 33-34+6 weeks.Conclusions: Serum magnesium level can be used as a predicting tool for preterm labor. Preterm labor can be avoided by simple supplementation of Magnesium which might provide an easy and inexpensive means to decrease the problems related to preterm labor. There is a further scope for research on serum magnesium levels based on gestational age.
ABSTRACT
Background: Stroke is a leading cause of death and disability worldwide acute ischaemic stroke accounts for 87% of strokes and mostly affects persons at the peak of their lives. Magnesium is known to have neuroprotective effects in ischemic stroke through a variety of mechanisms including decrease in glutamate release and inhibition of NMDA receptors and vasodilation. Previous studies on serum magnesium levels in stroke patients have shown variable results with many of them finding lower levels than in normal subjects. This study was undertaken to compare serum magnesium levels in patients of acute ischemic stroke with those of controls and also find a correlation if any between serum magnesium levels and neurological disability.Methods: This was a prospective non-interventional case-control study in which 50 patients of acute ischemic stroke in the age group of 20 to 80 years admitted in the department of Medicine Government Medical College Jammu from October 2019 to January 2020 were taken. Their serum magnesium levels were analysed within first 24 hours of admission and neurological disability was measured using modified Rankin Score. Serum magnesium levels were also estimated in 35 healthy controls for comparison.Results: Serum magnesium was lower in the study group (mean of 1.85±0.36) as compared to the control group (mean of 2.4±0.21) which was statistically significant (p value =0.001). Modified Rankin Score was 4 to 5 in 27 patients and 2 to 3 in 23 patients and it was negatively correlated with serum magnesium levels (r =-0.67).Conclusions: Ischemic stroke patients had lower serum magnesium levels as compared to healthy subjects in our study and also lower levels were seen in those with higher neurological disability.
ABSTRACT
Background: Hypertensive disorders of pregnancy (HDP) is a major cause of maternal, fetal morbidity and mortality complicating 10% of all gestations. As effective treatments are very limited, prediction of HDP occurrence is most importance. Though many biomarkers have shown relationship with HDP, serum magnesium (Mg) has shown better predictor as involved in maintaining vascular contractility, tone. This study is intended to analyse incidence of GHT and fetomaternal outcome in pregnant women with normal and low serum magnesium level measured at mid trimester (18-20 weeks).Methods: A total of 105 consecutive singleton pregnant women in between 18-20 weeks of gestation attending OBG outpatient department were enrolled. After obtaining the informed consent, structured proforma was used to collect demographic, clinical details. Serum magnesium was measured by the colorimetric method and study participants were divided into two groups based on Mg cut off 1.5 mg/dl and followed up throughout pregnancy for fetomaternal outcome.Results: This study results revealed that 35.2% (37/105) pregnant women had serum Mg level < 1.5 mg/dl and mean value of Mg of all participant is 1.7 mg/dl, just above the lower limit. During follow-up of these two groups, statistically significant correlation between serum Mg levels (< 1.5 mg/dl) with GHT (8/12) occurrence and pre term birth was found. Other fetomaternal outcome not had significant correlation.Conclusions: As per the findings, serum Mg concentration measurement in between 18-20 weeks can be considered as a one of the predictors for subsequent occurrence of maternal outcome of GHT and fetal outcome of pre-term birth.
ABSTRACT
Background: Attention-deficit/hyperactivity disorder (ADHD) is the most common neurobehavioral disorder of childhood and one of among the most prevalent chronic health conditions affecting school-age children. Magnesium is a crucial mineral and appropriate levels in the body are essential for normal cognitive function and mental health. Seventy-two to 96% of those diagnosed with ADHD have been found to be significantly deficient in magnesium. Studies have shown that in these patients, supplementation with magnesium improves attention and working memory and decreases anxiety, depression and emotional dysregulation. Objective of the study was to measure the serum levels of magnesium in children with attention deficit hyperactive disorder and to assess the relation between serum Magnesium levels and Attention deficit hyperactive disorder (ADHD).Methods: The study was conducted at Niloufer Institute of Child Health, which is tertiary care referral hospital and a teaching institute, affiliated under the esteemed Osmania Medical College, Hyderabad. Ethical committee clearance was taken before conducting the study, 50 cases of ADHD are selected from the outpatient department of the Psychiatry clinic for children and adolescents. And 50 controls are also selected for this study. Serum magnesium levels are assessed in both groups.Results: In ADHD group children with serum Magnesium level <1.5 meq/L are 24% whereas in control group it is 6%. When subgroups were analyzed, 25% of hyperactive ADHD group, 18.75% of inattentive ADHD group and 27.27% of combined ADHD group had serum magnesium levels of less than 1.5 meq/l.Conclusions: The study suggest that there is deficiency of magnesium in ADHD children when compared to healthy controls. Further, the study also recommends that further research is needed to help to identify the etiology, impact, and possible therapeutic implications of magnesium status in ADHD.
ABSTRACT
Background: Magnesium deficiency is a common problem in diabetic patients. Magnesium deficiency may increase the incidence of Type 2 Diabetic (T2D) and occurrence complications. Objective of this study aimed at determining the differences in serum magnesium levels and lipid profile among patients newly diagnosed with T2D and normoglycemic individuals.Methods: The cross sectional observation study design was conducted at Sri Aurobindo Medical College, from March 2018 to April 2019. Source populations were all patients who attending to the OPD, Department of General Medicine. A total of 75 patients were enrolled in this study. This study was divided in two group’s cases group (T2D) and second control group (Non-diabetic). First group not initiated on any oral-hypoglycaemic, anti-hypertensive or lipid lowering drugs, and healthy patients were included in control group.Results: Triglycerides (TG), Total Cholesterol (TC), low-density lipoprotein-cholesterol (LDL-C) showed significantly (p<0.001) higher mean levels in T2D compared to the controls. The Magnesium and High-Density Lipoproteins-cholesterol (HDL-C) levels were significantly (p<0.001) lower among the T2D group compared to the control group. There was a significant inverse correlation (r2= 0.567, p<0.001) between Hemoglobin A1C (HbA1c) levels and serum magnesium.Conclusions: Serum magnesium levels and lipid profile were significantly different in T2D patients compared to control group.
ABSTRACT
Background: Serum magnesium level in pregnancy is a valuable tool to find out preterm onset of labour. In the asymptomatic group, greater surveillance and administration of steroids, tocolytics and transfer to a higher centre wherever necessary has to be done with mothers with low serum magnesium level. The objective of the study is to find association between serum magnesium levels and women with preterm labour, and to compare these values with those patients who have a term delivery.Methods: The subjects included 100 pregnant women with preterm labour (cases) between 28 and 37 weeks gestation (Group A) and similar number of pregnant women with term labour (controls) between 37 and 40 weeks (Group B). Inclusion criteria for cases was singleton pregnancy, painful uterine contractions more than two in 30 minutes, intact fetal membranes, cervical dilatation (at least 1 cm) and effacement (80%). Serum magnesium levels were done in both the groups. Patients were followed until delivery. Routine antenatal investigations were done. Serum levels of magnesium were estimated by Erba’s semi auto-analyser.Results: 62% patients in Group A were from rural areas. More patients in Group A (70%) were from low socioeconomic class. More women in Group A were anaemic (44%). Mean value of hemoglobin in Group A was 9.93gm/dL. More patients in Group A had muscle cramps (89%). VLBW (<1500gm) neonates were more in Group A (21%). Also, LBW (1500-2499gm) neonates were more in Group A (60%). Mean neonatal birth weight in Group A (1907.3gm) was less. Neonatal morbidity and mortality was observed significantly more in Group A. Mean serum magnesium was less in Group A. Mean serum magnesium levels in primi and multigravida patients were less in Group A. Moreover, mean serum magnesium levels were less in urban and rural patients in Group A. Mean serum magnesium levels were less in normal and overweight patients in Group A. Also, mean serum magnesium levels were less in patients with cervical dilatation <3cm and >3cm in Group A.Conclusions: Low maternal serum magnesium level is associated with preterm labour. Patients with preterm labour have significantly low serum magnesium level when compared with labour at term.
ABSTRACT
Magnesium is an incredibly vital mineral found in the human body. Magnesium clearly affects the entire body and naturally will interact with thyroid functions, both directly and indirectly. Objectives: To assess the levels of serum magnesium in patients with hypothyroidism and its correlation with TSH levels. Methodology: An observational study consists of 174 cases of hypothyroidism were selected. All patients with hypothyroidism, newly diagnosed with age above 18years were included, all patients with malignancy, multiple endocrine disorder, CKD and patients supplemented with minerals were excluded in the study. Thyroid function and serum magnesium levels were done and analyzed in these patients. Results: In our study mean serum magnesium level in hypothyroid cases was 2.18±0.02 mg/dl. Our study done with a follow up of thyroid function and serum magnesium level in hypothyroidism after supplementation with thyroid hormone and diet supplementation for magnesium showed a significant improvement which reciprocate the incidence of hypo magnesium in hypothyroidism and which is inversely proportionate to TSH levels which was not statistically significant. Conclusion: The alteration of serum magnesium level in hypothyroidism was not established in our study statistically.
ABSTRACT
Introduction: CD34 Immunohistochemical antigen serves as a tool in differentiating between benign and malignant conditions. Hence, the study was conducted to determine the stromal expression of CD34 antigen by immunohistochemical method in proliferative lesions of the breast and to evaluate the loss of CD34 antigen expression in stromal cells is specific for malignant lesions. Materials and methods: 108 cases of proliferative lesions of the breast were studied from January 2016 to December 2017 for some time of 2 years. Paraffin-embedded blocks were retrieved for all the cases and underwent routine processing followed by Hematoxylin and Eosin staining. 84 cases of the benign lesion, one case of the borderline lesion and 23 cases of the malignant lesion were studied for CD34 immunohistochemical staining, and semi-quantitative assessment was done. Results: On Hematoxylin and Eosin staining, we have found benign lesions includes 63 cases of fibroadenoma, 7, 4, and 3 cases of the fibrocystic disease, fibro adenosis and fibroadenoma respectively with apocrine metaplasia. Malignant lesions include 22 cases of infiltrating ductal carcinoma, one case of infiltrating lobular carcinoma. One case of borderline phyllodes tumor was also included in this study. In normal breast tissue, stroma was positive for CD34 IHC stain. All the malignant cases are showing loss of CD34 staining. Only one case of borderline phyllodes tumor shows grade 2 staining with CD 34 Antigen. Conclusion: We can concluded that the use of CD34 Immunohistochemical marker positivity as an adjuvant tool in differentiating between benign and malignant conditions where the morphology is equivocal.
ABSTRACT
Background: Myocardial infarction which is an outcome measure in clinical trials, observational studies and quality assurance program have several conventional risk factors which include older age, hypertension, diabetes, decreased physical activity, alcohol intake, smoking, abdominal obesity, highrisk diet, psychological stress. Hypomagnesemia and means platelet volume is now recognized as a significant risk factor for atherogenesis, and thus for hypertension, ischemic heart disease, cardiac arrhythmias, coronary vasospasm, sudden cardiac death, cerebrovascular accident, and myocardial infarction. The aim of the study: To determining the relationship between serum Magnesium levels on platelet reactivity in Acute Myocardial infarction. Therefore in this study, we attempted to find the impact of serum Magnesium level on the Mean Platelet Volume and the use of these parameters as novel biomarkers to predict AMI. Materials and methods: A case-control study was carried out in the Department of Cardiology, Govt. Royapettah Hospital/ Kilpauk Medical College. Totally 88 Acute Myocardial Infarction patients (for the estimated prevalence of 30.36% in urban Indian population) admitted in the Intensive Coronary Care Unit between July to October 2015 and 88 age and sex-matched apparently normal individuals were included. Fasting venous peripheral blood samples were drawn within 48 hours of admission. Blood samples were taken into standardized trisodium citrate tubes (stored at room N. Jayaprakash, V. Madhavan, Aswanaa Kamanuru Govindarajulu. Serum magnesium levels and mean platelet volume (MPV) as biomarkers in acute myocardial infarction. IAIM, 2019; 6(4): 1-8. Page 2 temperature) and a sterile vacutainer which was serum separated, aliquoted into 2 Eppendorf’s and stored at minus 20 º C until further analysis. Results: Both the Systolic and Diastolic Blood pressure was significantly elevated in the cases (p= 0.000) which was statistically significant. The Fasting Blood Glucose levels were raised in AMI patients (p=0.001) although only 38.6% were known Diabetics. Urea levels were increased in cases (p=0.007) which was significant. The serum magnesium values were significantly lower in AMI patients in comparison to the normal individuals (p= 0.000) and the Mean Platelet Volume was significantly elevated in the cases than the control (p=0.004). Conclusion: Our study demonstrated that Magnesium levels were reduced in AMI patients and that Mean platelet Volume was elevated in AMI patients however a cause-effect relationship between the two parameters was not established. However, we propose that MPV and Magnesium may be useful biomarkers in identifying patients with increased risk for AMI. Further, a cohort study design including all the confounding variables can better address their relationship and role as adjuvant biomarkers in the diagnosis of AMI.
ABSTRACT
Background: There is a complex interrelationship in the co-existence of thyroid dysfunction among diabetic patients and may be related to the development of cardiovascular diseases and other complications of long term metabolic derangements. The prevalence of thyroid dysfunction varies from 10 to 24% among diabetic patients. The objective of the present study was to determine the prevalence of thyroid dysfunction among the patients with diabetes mellitus in a tertiary care hospital at Puducherry, India.Methods: This retrospective study was conducted during June 2018 analysing the records of diabetes patients attending to the diabetes OPD, Department of General Medicine in the past one year and their association with thyroid dysfunction was studied.Results: Among the study participants (n=200), 14.5% (n=29) were Type I diabetics and 85.5% (n=171) were type II Diabetes patients. The prevalence of Thyroid Dysfunction (TD) among the study participants was 28.5% (n=57). The proportion of TD was higher among type 1 DM compared to type 2 (p<0.001). The prevalence of subclinical hypothyroidism was more (n=7, 24.1%) among type 1DM compared to type II DM patients (p=0.05).Conclusions: There was a higher prevalence of TD among the diabetics. TD was more frequent among type 1 DM compared to Type 2 DM patients and the most frequent TD associated with diabetes was subclinical hypothyroidism.
ABSTRACT
Background@#Serum magnesium levels are usually measured and corrected, if warranted, among patients with cardiac diseases. @*Objective@#To determine the rate of and clinical factors associated with hypomagnesemia among patients with cardiac conditions. @*Design@#Cross-sectional study. @*Setting@#Davao Regional Medical Center (DRMC) in Tagum City, Philippines, from January 2014 to January 2016. @*Participants@#59 males and 53 females with cardiac diagnoses and serum magnesium level determination results. @*Main outcome measures@#Rate of hypomagnesemia, odds ratios (95% CI) of having hypomagnesemia for selected clinical factors.
Subject(s)
Atrial Fibrillation , Stroke , Pulmonary Disease, Chronic Obstructive , DiureticsABSTRACT
Background@#Serum magnesium levels are usually measured and corrected, if warranted, among patients with cardiac diseases. @*Objective@#To determine the rate of and clinical factors associated with hypomagnesemia among patients with cardiac conditions. @*Design@#Cross-sectional study. @*Setting@#Davao Regional Medical Center (DRMC) in Tagum City, Philippines, from January 2014 to January 2016. @*Participants@#59 males and 53 females with cardiac diagnoses and serum magnesium level determination results. @*Main outcome measures@#Rate of hypomagnesemia, odds ratios (95% CI) of having hypomagnesemia for selected clinical factors.
Subject(s)
Atrial Fibrillation , Stroke , Pulmonary Disease, Chronic Obstructive , DiureticsABSTRACT
Objective To explore the relationship between serum magnesium level,abdominal aortic calcification(AAC) and mineral metabolism in continuous ambulatory peritoneal dialysispatients.Methods Sixty-two cases patients who were on Continuous Ambulatory Peritoneal Dialysis in Pritoneal Dialysis Center of Qingdao Municipal Hospital were enrolled prospectively.The AAC was detected by abdomen lateral plain radiographs,and the AAC score(AACs) was calculated.According to the AACs,the patients were divided into group A(AACs≤4 points) and group B(from >4 point to ≤15 point) and group C(AACs>15 point).And collected the patient′s clinical data and blood biochemical indicators.The serum magnesium levels of 3 groups were observed,and explored the relationship of serum magnesium and intact parathyroid hormone(iPTH),serum calcium,serum phosphorus.Results There were 41 cases of vascular calcification in 62 cases maintenance ambulatory peritoneal dialysis patients,and its incidence was 66.13%.Group levels of serum magnesium were in group A was (1.00±0.18) mmol/L,(0.89±0.10) mmol/L of group B,and (0.75±0.13) mmol/L of group C,the mean differences were significant(F=11.99,P0.05).Conclusion Vascular is the calcification frequent complications in continuous ambulatory peritoneal dialysis patients.The serum level of serum magnesium may be correlated with the AAC,iPTH,serum phosphorus.